VANCOUVER, British Columbia, May 5, 2015 /PRNewswire/ — InMed Pharmaceuticals Inc. (“InMed”) (CSE: IN; OTCQB: IMLFF), a clinical stage biopharmaceutical company that specializes in developing safer, more effective cannabis-based therapies, announced today that former GW…


Source: PrNewwire

Related Posts Plugin for WordPress, Blogger...